Eicosanoids metabolized through LOX distinguish asthma–COPD overlap from COPD by metabolomics study

BACKGROUND AND OBJECTIVE: The prevalence of asthma is greater than 20% in patients previously diagnosed with COPD. Patients with asthma–COPD overlap (ACO) are at risk of rapid progression of disease and severe exacerbations. However, in some patients with ACO, a clear distinction from COPD is very d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Chron Obstruct Pulmon Dis
Main Authors: Cai, Chuanxu, Bian, Xiqing, Xue, Mingshan, Liu, Xiaoqing, Hu, Haisheng, Wang, Jingxian, Zheng, Song Guo, Sun, Baoqing, Wu, Jian-Lin
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689553/
https://ncbi.nlm.nih.gov/pubmed/31496676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S207023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados